Executive Profile

Tracy S. Warren Chairman and Acting Chief Executive Officer, NellOne Therapeutics, Inc.

Age	Total Calculated Compensation	This person is connected to 5 Board Members in 5 different organizations across 6 different industries. See Board Relationships
--	--

Background

Ms. Tracy S. Warren serves as a General Partner at Battelle Ventures. Ms. Warren is also a General Partner at Innovation Valley Partners. Ms. Warren focuses on investments in health and life sciences and emerging energy technologies. Ms. Warren serves as an Acting Chief Executive Officer and Chairman of the Board of NellOne Therapeutics, Inc. She works closely on identifying promising technologies, projects, and synergies with the National Laboratories that sole limited ... partner Battelle manages or co-manages for the U.S. Department of Energy around the country. With the funding of Endovalve, she pioneered the fund’s virtual company investment model, in which typical infrastructure expenses are minimized during a company’s initial high-risk phase. She was employed at Cowen and Company, LLC and JPMorgan Chase & Co. Ms. Warren also uses this capital-efficient model with NellOne. Ms. Warren joined ESE part-time in early 2000. She was an Associate of Early Stage Enterprises, LP (ESE) since June 2001. Prior to ESE, she worked at GE Equity in the Health Care and Financial Services Group and consulted to several health care ventures including a proteomics company, a clinical trial consulting business, and a generic pharmaceutical company. Ms. Warren started in venture capital in 2001 after spending three years at SG Cowen Securities in its Health Care Mergers and Acquisitions as an Analyst and Corporate Finance divisions as an Associate, where she focused primarily on companies in the medical device and health care information technology fields. Earlier in her career, she spent a year at Chase Manhattan Bank in its Global Financial Analyst program in the utilities and natural resource group. She serves as the Member of the Board of Directors at Micro Interventional Devices, Inc. Ms. Warren serves on the Board of Directors of Metatomix, Inc. and serves as a Board Observer of NuPathe, SmartSynch, Superprotonic, and Ventaira Pharmaceuticals. She has been the Chairman of BioNano Genomics, Inc. since December 2009 and serves as its Director. She served as a Director of Endovalve, Inc. She served as a Director of Endovalve, Inc. Ms. Warren serves on Battelle Memorial Institute’s Commercialization Council. She earned an M.B.A. from Columbia Business School in May 2001 and a B.S. in Accounting and International Business from New York University Stern School of Business in 1995.

Corporate Headquarters 10702 Murdock Road Knoxville, Tennessee 37932 United States Phone: 865-777-1414 Fax: 865-777-1417 Board Members Memberships Director Metatomix, Inc. Chairman BioNano Genomics, Inc. Director Endovalve, Inc. Chairman and Acting Chief Executive Officer NellOne Therapeutics, Inc. Member of the Board of Directors Micro Interventional Devices, Inc. Education MBA 2001 Columbia Business School BS 1995 New York University - Leonard N. Stern School of Business Other Affiliations Ben Franklin Technology Partners of Southeastern Pennsylvania, Investment Arm Early Stage Enterprises, LP JPMorgan Chase & Co. Columbia Business School New York University - Leonard N. Stern School of Business Metatomix, Inc. Early Stage Enterprises, L.P. BioNano Genomics, Inc. Battelle Ventures Innovation Valley Partners Cowen and Company, LLC Endovalve, Inc. Micro Interventional Devices, Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.